Xiaonan Wang

State Key Laboratory of Chemical Engineering

Also affiliated with Beijing University of Chemical Technology, Tsinghua University

EnergyMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma”.

Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma

Nature Communications(2020)10.1038/s41467-020-19855-x

N/A

0DataRank · unranked

31 citations

Mulong Du, Jingyuan Zhang, Weizhang Xu, Qianyu Yuan, Ming Li +12 more

Stromal inflammation is a targetable driver of hematopoietic aging

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.08.434485

N/A

0DataRank · unranked

3 citations

Carl A. Mitchell, Fernando J. Calero‐Nieto, Aurélie Hérault, Paul V. Dellorusso, Xiaonan Wang +8 more

Stromal inflammation is a targetable driver of hematopoietic aging

Research Square(2021)10.21203/rs.3.rs-1065222/v1

N/A

0DataRank · unranked

1 citations

Evgenia Verovskaya, Fernando J. Calero‐Nieto, Oakley C. Olson, Xiaonan Wang, Aurélie Hérault +10 more

Stromal niche inflammation mediated by IL-1 signalling is a targetable driver of haematopoietic ageing

Nature Cell Biology(2023)10.1038/s41556-022-01053-0

N/A

0DataRank · unranked

203 citations

Evgenia Verovskaya, Fernando J. Calero‐Nieto, Oakley C. Olson, James W. Swann, Xiaonan Wang +10 more

1633P Phase III study of talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA as first-line (1L) treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): TALAPRO-2 (TP-2) China cohort

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1714

N/A

0DataRank · unranked

0 citations

D. Ye, Hanxu Guo, Yuchong Yang, Bing Xue, Xiao Zhang +15 more